Analytical Data
-
Gene name
EMR1
- Application
-
Alternative Names
TM7LN3; EGF-like module receptor 1; EMR1 hormone receptor
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q14246
-
Expression Region
Met1~Pro201
-
Molecular Weight
29kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EMR1 (Epithelial Mucinosis Receptor 1) is a member of the epidermal growth factor (EGF) receptor family, predominantly expressed in specific immune cells, including macrophages and dendritic cells. Recent studies have highlighted the role of EMR1 in modulating immune responses, particularly in the context of inflammation and allergic reactions. Its unique ability to influence the activation and functional polarization of immune cells makes EMR1 an important target for understanding the pathways underlying various diseases, including asthma and autoimmune disorders. The production and characterization of EMR1 recombinant proteins are essential for elucidating its biological functions and interaction mechanisms. By generating a high-purity EMR1 protein through techniques such as recombinant DNA technology, researchers can explore its structural properties and biological activities, facilitating the development of potential therapeutic strategies. Understanding the signaling pathways involving EMR1 may provide insights into novel immunotherapeutic approaches and enhance our knowledge of its implications in health and disease. Therefore, the investigation of EMR1 recombinant protein serves as a pivotal step in advancing our comprehension of immune regulation and its potential applications in clinical settings.
